Immunomodulatory Nanoparticles and Their Advancement in Health

Immunomodulatory nanoparticles are an advancing field in healthcare that has the potential to revolutionize disease diagnosis, treatment, and prevention. These nanoparticles interact with the immune system, either enhancing or suppressing its activity, to achieve therapeutic outcomes. The advancements in nanotechnology have opened up new possibilities for developing diverse types of immunomodulatory nanoparticles. These include liposomes, polymeric nanoparticles, and metallic nanoparticles. These breakthroughs have revolutionized the field, driving significant progress in immunomodulation research. These nanoparticles can be precisely engineered in terms of size, surface properties, and cargo content, allowing customization for specific diseases and desired therapeutic effects. Immunotherapy is becoming widely acknowledged as a highly effective strategy for prevention and treatment across various illnesses. These include cancer, infectious diseases, inflammatory disorders, and autoimmune diseases. The expanding recognition of immunotherapy’s efficacy positions it as a leading approach in advancing medical interventions against these conditions. Immunomodulatory nanosystems have the potential to significantly improve therapeutic outcomes while addressing challenges associated with treatment approaches, such as insufficient immune activation, off-target effects, and loss of bioactivity during circulation. Researchers have been actively developing novel nanomaterials with unique structures, characteristics, and activities. Ongoing research and development in this field will lead to innovative therapeutic approaches and improved patient outcomes. This chapter of the book presents the latest achievements in nanotechnology for immunostimulation and immunosuppression. It explores the development of immunomodulatory nanosystems using biodegradable and immunologically inert components to activate the immune system through dendritic cell maturation, macrophage activation, and antibody-mediated activation. The chapter also discusses the significance of size, shear rate, and vessel shape in these nanosystems’ absorption, transport, and retention. Finally, it highlights immunotherapy as an emerging therapeutic option for various human diseases.